LONDON, UK – May 5, 2022 – Eternal Bioworks Corp. (“ETERNAL” or the “Company”), a leading biotech company dedicated to advancing the intersection of technology and biology to address some of the most critical challenges facing our planet, reaffirms its commitment to advancing the alternative protein industry, aligning with the key findings from the Good Food Institute’s (GFI) 2022 report. GFI’s recent report underscores significant trends and advancements reshaping the landscape of alternative proteins, with a strong focus on sustainability, innovation, and consumer demand.
Key Findings for Alternative Proteins in 2022:
- Diverse Protein Sources: The industry is diversifying, exploring new protein sources beyond traditional plant-based options, including fungi, algae, and fermentation-derived proteins.
- Nutritional Enhancement: Innovations are improving the nutritional profiles of alternative proteins, addressing deficiencies, and ensuring competitive nutritional value compared to animal-based proteins.
- Technological Innovation: Advances in biotechnology and food processing are driving improvements in production efficiency, reducing costs, and enhancing the scalability of alternative protein products.
- Cultured Meat Advancements: Significant progress has been made in cultured meat technologies, with increased investments and developments aimed at achieving commercial scalability and market acceptance.
- Consumer Acceptance: Alternative proteins are gaining wider consumer acceptance due to improvements in taste, texture, and affordability, aligning with shifting dietary preferences towards healthier and more sustainable food choices.
- Regulatory Support: Evolving regulatory frameworks are accommodating the unique characteristics and safety considerations of alternative protein products, supporting market growth and consumer confidence.
- Global Market Expansion: The global market for alternative proteins is expanding rapidly, driven by growing awareness of environmental sustainability and ethical considerations among consumers worldwide.
ETERNAL’s Vision for Alternative Proteins
ETERNAL is dedicated to leading the charge in sustainable food innovation, leveraging GFI’s key findings to shape its strategies and product development. ETERNAL’s flagship product, Mycofood™, exemplifies its commitment to offering sustainable, nutritious, and delicious alternatives that meet the evolving demands of today’s consumers.
By embracing diverse protein sources, enhancing nutritional profiles, and driving technological innovation, ETERNAL continues to push the boundaries of what’s possible in the alternative protein industry. The company’s focus on consumer acceptance and regulatory support ensures that its products not only meet but exceed market expectations.
As the global market for alternative proteins grows, ETERNAL remains at the forefront, pioneering solutions that promote environmental sustainability and ethical food production. With Mycofood™ and other innovative products, ETERNAL is poised to lead the way towards a more sustainable and nutritious future for all.
About Eternal Bioworks Corp.
Eternal Bioworks Corp. is at the forefront of biotechnological innovation, dedicated to advancing the intersection of technology and biology to address some of the most critical challenges facing our planet. Founded with the vision to revolutionize food systems and material production, Eternal leverages cutting-edge advancements in artificial intelligence, robotics, and bioprocessing to create sustainable solutions that are not only viable but vital for the future.
For more information, please contact us at [email protected]
